Ablation of IL-17 Expression Moderates Experimental Autoimmune Myasthenia Gravis Disease Severity.

Authors

Gabriela Aguilo-Seara, George Washington University
Yanchen Xie, George Washington University
Jarrod Sheehan, George Washington University
Linda L Kusner, George Washington UniversityFollow
Henry J Kaminski, George Washington UniversityFollow

Document Type

Journal Article

Publication Date

6-6-2017

Journal

Cytokine

Volume

96

DOI

10.1016/j.cyto.2017.05.008

APA Citation

Aguilo-Seara, G., Xie, Y., Sheehan, J., Kusner, L., & Kaminski, H. (2017). Ablation of IL-17 Expression Moderates Experimental Autoimmune Myasthenia Gravis Disease Severity.. Cytokine, 96 (). http://dx.doi.org/10.1016/j.cyto.2017.05.008

Peer Reviewed

1